[1] Masarone M,Federico A,Abenavoli L,et al.Non alcoholic fatty liver:epidemiology and natural history. Rev Recent Clin Trials,2014,9(3):126-133. [2] 赵文霞,张丽慧. 合理应用中成药治疗非酒精性脂肪性肝病. 实用肝脏病杂志,2017,20(2):132-134. [3] 成扬,龚亚华,张银华,等. 健脾理气化湿方配方颗粒治疗脾虚湿热型非酒精性脂肪性肝炎患者疗效及对FFA,HOMA-IR,APRI的影响. 中国实验方剂学杂志,2017,23(17):200-204. [4] Cheung O,Puri P,Eicken C,et al.Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology,2008,48(6):1810-1820. [5] 虢灿杰,潘勤,李定国. microRNAs在肝病中的研究进展. 胃肠病学,2010,15(3):175-177. [6] 高胜楠,宁宝森,邹春燕,等. microRNAs在肝病中的研究进展. 现代生物医学进展,2014,14(22):4386-4389. [7] Yki-Jarvinen H.Diagnosis of non-alcoholic fatty liver disease (NAFLD). Diabetologia,2016,290(6):1104-1111. [8] 肖丽萍,余新沛,刘岗,等. 多烯磷脂酰胆碱联合维生素E治疗非酒精性脂肪性肝炎合并2型糖尿病患者效果研究. 实用肝脏病杂志,2016,19(2):172-175. [9] Gaggini M,Morelli M,Buzzigoli E,et al.Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance,dyslipidemia,atherosclerosis and coronary heart disease. Nutrients,2013,5(5):1544-1560. [10] Sumida Y,Niki E,Naito Y,et al.Involvement of free radicals and oxidative stress in NAFLD/NASH. Free Rad Res,2013,47(11):869-880. [11] Ling L,Lu B,Yu J,et al.Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage. Clin Res Hepatol Gastroenterol,2016,40(4):397-404. [12] Gao W,Yu Y,Cao H,et al.Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother,2010,64(6):399-408. [13] 丁洁霞. MicroRNA-34a在非酒精性脂肪性肝病中的作用及机制研究. 浙江大学,2015. [14] 陈凤华, 樊飞跃. Sirt3 抗癌变作用的研究进展. 中华肿瘤防治杂志,2012,19(15):1193-1195. [15] 林凯丽,王彦,王津晗,等. Sirt3的作用机制及抗肿瘤研究进展. 中国工业医学杂志,2014,27(4):287-289. [16] Zhang B,Cui S,Bai X,et al.SIRT3 overexpression antagonizes high glucose accelerated cellular senescence in human diploid fibroblasts via the SIRT3-FOXO1 signaling pathway. AGE, 2013,35(6):2237-2253. [17] 马路,杨晔. Sirt3与线粒体适应. 医学综述, 2015, 21(2):406-409. [18] 盛俊. HIF-1通过FOXO1清除胰腺癌细胞内ROS的体内外研究. 天津医科大学,2012. [19] 陈娟,孔维宗,梁凯,等. 白藜芦醇对非酒精性脂肪性肝炎大鼠肝组织SIRT3表达的影响. 实用肝脏病杂志,2017,20(4):402-407. |